Applying Proteogenomics to Identify Cancer’s Non-Canonical Alternative Neoantigens and the Development of Immunotherapies Targeting Those Antigens and Other SLiPs

B Fox

Applying Proteogenomics to Identify Cancer’s Non-Canonical Alternative Neoantigens and the Development of Immunotherapies Targeting Those Antigens and Other SLiPs

Research output: Other contribution

Abstract

Tumor Immunology Meets Oncology (TIMO); 2023 April 22; Halle, Germany

Original language	American English
State	Published - Apr 22 2023

Publication series

Name	Articles, Abstracts, and Reports

Access to Document

http://digitalcommons.providence.org/publications/7973

Cite this

@misc{5fdaf698c8b0459b9ee7c9f2c2df41e4,

title = "Applying Proteogenomics to Identify Cancer{\textquoteright}s Non-Canonical Alternative Neoantigens and the Development of Immunotherapies Targeting Those Antigens and Other SLiPs",

abstract = "Tumor Immunology Meets Oncology (TIMO); 2023 April 22; Halle, Germany",

author = "B Fox",

year = "2023",

month = apr,

day = "22",

language = "American English",

series = "Articles, Abstracts, and Reports",

type = "Other",

}

TY - GEN

T1 - Applying Proteogenomics to Identify Cancer’s Non-Canonical Alternative Neoantigens and the Development of Immunotherapies Targeting Those Antigens and Other SLiPs

AU - Fox, B

PY - 2023/4/22

Y1 - 2023/4/22

N2 - Tumor Immunology Meets Oncology (TIMO); 2023 April 22; Halle, Germany

AB - Tumor Immunology Meets Oncology (TIMO); 2023 April 22; Halle, Germany

M3 - Other contribution

T3 - Articles, Abstracts, and Reports

ER -

Applying Proteogenomics to Identify Cancer’s Non-Canonical Alternative Neoantigens and the Development of Immunotherapies Targeting Those Antigens and Other SLiPs

Abstract

Publication series

Access to Document

Fingerprint

Cite this